Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 71335-9708

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 71335-9708). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (8ae77338 81c1 4b29 992d 318d0549cf39 01)

Figure (8ae77338 81c1 4b29 992d 318d0549cf39 01)
Chemical structure of diltiazem hydrochloride showing its molecular composition including aromatic rings and functional groups associated with the active ingredient.*
FDA Label Image

Label (Lbl713359708)

Label (Lbl713359708)
Label for diltiazem hydrochloride extended-release capsules, USP 180 mg, NDC 71335-9708-1. The label indicates 30 capsules in the package, with repackaging by Bryant Ranch Prepack, Inc., Burbank, CA, and manufacturing by Cadila Healthcare Limited. Storage and handling instructions and a QR code are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.